B Cell Lymphoma

Perspectives

Primary CNS lymphoma: R-CHOP hits back

Twenty years after it was concluded that there was no role for R-CHOP in the treatment of primary CNS lymphoma, researchers are reconsidering that...

Conference Coverage

Decoding biosimilar approvals

SAN FRANCISCO – Regulators must consider several factors when expanding the use of an approved biosimilar from one indication to another, based on...

Pages